Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Discover expert-backed wellness resources
MOUNJARO is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]
The STEP trial series demonstrated that semaglutide 2.4 mg weekly produces approximately 17-22% weight reduction from baseline over 68 weeks
These risks include effects on organ development, fetal weight, and even a higher likelihood of pregnancy loss in some cases
US$ 29.20
US$ 22.50
US$ 25.35
US$ 20.54
US$ 20.22
US$ 29.77
US$ 25.18
US$ 22.72
US$ 22.79
US$ 20.62
